Goodnow, C.C., Multistep pathogenesis of autoimmune disease (2007) Cell, 130, pp. 25-35
Rahman, A., Isenberg, D.A., Systemic lupus erythematosus (2008) New England Journal of Medicine, 358 (9), pp. 929-939. , http://content.nejm.org/cgi/reprint/358/9/929.pdf, DOI 10.1056/NEJMra071297
Gregersen, P.K., Olsson, L.M., Recent advances in the genetics of autoimmune disease (2009) Annu Rev Immunol, 27, pp. 363-391
Anders, H.J., Pseudoviral immunity - A novel concept for lupus (2009) Trends Mol Med, 15, pp. 553-561
Marshak-Rothstein, A., Rifkin, I.R., Immunologically active autoantigens: The role of Toll-like receptors in the development of chronic inflammatory disease (2007) Annual Review of Immunology, 25, pp. 419-441. , DOI 10.1146/annurev.immunol.22.012703.104514
Anders, H.J., Krug, A., Pawar, R.D., Molecular mimicry in innate immunity? The viral RNA recognition receptor TLR7 accelerates murine lupus (2008) Eur J Immunol, 38, pp. 1795-1799
Lenert, P., Yasuda, K., Busconi, L., Nelson, P., Fleenor, C., Ratnabalasuriar, R.S., Nagy, P.L., Marshak-Rothstein, A., DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Faslpr/lpr mice in vivo (2009) Arthritis Res Ther, 11, pp. 1-16
Patole, P.S., Zecher, D., Pawar, R.D., Grone, H.-J., Schlondorff, D., Anders, H.-J., G-rich DNA suppresses systemic lupus (2005) Journal of the American Society of Nephrology, 16 (11), pp. 3273-3280. , DOI 10.1681/ASN.2005060658
Pawar, R.D., Ramanjaneyulu, A., Kulkarni, O.P., Lech, M., Segerer, S., Anders, H.-J., Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus (2007) Journal of the American Society of Nephrology, 18 (6), pp. 1721-1731. , DOI 10.1681/ASN.2006101162
Allam, R., Lichtnekert, J., Moll, A.G., Taubitz, A., Vielhauer, V., Anders, H.J., Viral RNA and DNA trigger common antiviral responses in mesangial cells (2009) J Am Soc Nephrol, 20, pp. 1986-1996
Allam, R., Pawar, R.D., Kulkarni, O.P., Hornung, V., Hartmann, G., Segerer, S., Akira, S., Anders, H.J., Viral 5′-triphosphate RNA and non-CpG DNA aggravate autoimmunity and lupus nephritis via distinct TLRindependent immune responses (2008) Eur J Immunol, 38, pp. 3487-3498
Anders, H.J., Vielhauer, V., Eis, V., Linde, Y., Kretzler, M., Perez De Lema, G., Strutz, F., Schlondorff, D., Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice (2004) FASEB J, 18, pp. 534-536
Pawar, R.D., Patole, P.S., Zecher, D., Segerer, S., Kretzler, M., Schlondorff, D., Anders, H.J., Toll-like receptor-7 modulates immune complex glomerulonephritis (2006) J Am Soc Nephrol, 17, pp. 141-149
Krieg, A.M., Yi, A.K., Matson, S., Waldschmidt, T.J., Bishop, G.A., Teasdale, R., Koretzky, G.A., Klinman, D.M., CpG motifs in bacterial DNA trigger direct B-cell activation (1995) Nature, 374, pp. 546-549
Haupt, Y., Maya, R., Kazaz, A., Oren, M., Mdm2 promotes the rapid degradation of p53 (1997) Nature, 387 (6630), pp. 296-299. , DOI 10.1038/387296a0
Honda, R., Tanaka, H., Yasuda, H., Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 (1997) FEBS Letters, 420 (1), pp. 25-27. , DOI 10.1016/S0014-5793(97)01480-4, PII S0014579397014804
Green, D.R., Kroemer, G., Cytoplasmic functions of the tumour suppressor p53 (2009) Nature, 458, pp. 1127-1130
Vazquez, A., Bond, E.E., Levine, A.J., Bond, G.L., The genetics of the p53 pathway, apoptosis and cancer therapy (2008) Nat Rev Drug Discov, 7, pp. 979-987
Forte, E., Luftig, M.A., MDM2-dependent inhibition of p53 is required for Epstein-Barr virus B-cell growth transformation and infected-cell survival (2009) J Virol, 83, pp. 2491-2499
Cohen, P.L., Eisenberg, R.A., Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease (1991) Annu Rev Immunol, 9, pp. 243-269
Vassilev, L.T., Vu, B.T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Liu, E.A., In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 (2004) Science, 303 (5659), pp. 844-848. , DOI 10.1126/science.1092472
Reeves, W.H., Chaudhary, N., Salerno, A., Blobel, G., Lamin B autoantibodies in sera of certain patients with systemic lupus erythematosus (1987) Journal of Experimental Medicine, 165 (3), pp. 750-762. , DOI 10.1084/jem.165.3.750
Neubert, K., Meister, S., Moser, K., Weisel, F., Maseda, D., Amann, K., Wiethe, C., Voll, R.E., The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis (2008) Nature Medicine, 14 (7), pp. 748-755. , DOI 10.1038/nm1763, PII NM1763
Bidere, N., Su, H.C., Lenardo, M.J., Genetic disorders of programmed cell death in the immune system (2006) Annu Rev Immunol, 24, pp. 321-352
Kotzin, B.L., Systemic lupus erythematosus (1996) Cell, 85, pp. 303-306
Khosravi, R., Maya, R., Gottlieb, T., Oren, M., Shiloh, Y., Shkedy, D., Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage (1999) Proceedings of the National Academy of Sciences of the United States of America, 96 (26), pp. 14973-14977. , DOI 10.1073/pnas.96.26.14973
Kono, H., Rock, K.L., How dying cells alert the immune system to danger (2008) Nature Reviews Immunology, 8 (4), pp. 279-289. , DOI 10.1038/nri2215, PII NRI2215
Zhang, F., Tagen, M., Throm, S., Mallari, J., Miller, L., Guy, R.K., Dyer, M.A., Stewart, C.F., Whole-body physiologically based pharmacokinetic model for nutlin-3a in mice after intravenous and oral administration (2011) Drug Metab Dispos, 39, pp. 15-21
Gurtner, G.C., Werner, S., Barrandon, Y., Longaker, M.T., Wound repair and regeneration (2008) Nature, 453 (7193), pp. 314-321. , DOI 10.1038/nature07039, PII NATURE07039
Hotchkiss, R.S., Strasser, A., McDunn, J.E., Swanson, P.E., Cell death (2009) N Engl J Med, 361, pp. 1570-1583
Levine, A.J., The common mechanisms of transformation by the small DNA tumor viruses: The inactivation of tumor suppressor gene products: p53 (2009) Virology, 384, pp. 285-293
Sarek, G., Kurki, S., Enback, J., Iotzova, G., Haas, J., Laakkonen, P., Laiho, M., Ojala, P.M., Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas (2007) Journal of Clinical Investigation, 117 (4), pp. 1019-1028. , http://www.jci.org/cgi/reprint/117/4/1019, DOI 10.1172/JCI30945
Coll-Mulet, L., Iglesias-Serret, D., Santidrian, A.F., Cosialls, A.M., De Frias, M., Castano, E., Campas, C., Gil, J., MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells (2006) Blood, 107 (10), pp. 4109-4114. , http://www.bloodjournal.org/cgi/reprint/107/10/4109, DOI 10.1182/blood-2005-08-3273
Shangary, S., Wang, S., Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: A novel approach for cancer therapy (2009) Annu Rev Pharmacol Toxicol, 49, pp. 223-2241
Vassilev, L.T., MDM2 inhibitors for cancer therapy (2007) Trends Mol Med, 13, pp. 23-31
Munz, C., Lunemann, J.D., Getts, M.T., Miller, S.D., Antiviral immune responses: Triggers of or triggered by autoimmunity? (2009) Nat Rev Immunol, 9, pp. 246-258
Guiducci, C., Gong, M., Xu, Z., Gill, M., Chaussabel, D., Meeker, T., Chan, J.H., Barrat, F.J., TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus (2010) Nature, 465, pp. 937-941
Scaffidi, P., Misteli, T., Bianchi, M.E., Release of chromatin protein HMGB1 by necrotic cells triggers inflammation (2002) Nature, 418 (6894), pp. 191-195. , DOI 10.1038/nature00858
Kulkarni, O.P., Sayyed, S.G., Kantner, C., Ryu, M., Schnurr, M., Sardy, M., Leban, J., Anders, H.J., 4SC-101, a novel small molecule dihydroorotate dehydrogenase inhibitor, suppresses systemic lupus erythematosus in MRL-(Fas)lpr mice (2010) Am J Pathol, 176, pp. 2840-2847
Rocha, B., Penit, C., Baron, C., Vasseur, F., Dautigny, N., Freitas, A.A., Accumulation of bromodeoxyuridine-labeled cells in central and peripheral lymphoid organs: Minimal estimates of prodution and turnover rates of mature lymphocytes (1990) European Journal of Immunology, 20 (8), pp. 1697-1708. , DOI 10.1002/eji.1830200812
